These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6806984)

  • 1. Control of large-scale plasma thawing for recovery of cryoprecipitate factor VIII.
    Foster PR; Dickson AJ; McQuillan TA; Dickson IH; Keddie S; Watt JG
    Vox Sang; 1982; 42(4):180-9. PubMed ID: 6806984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microwave-thawed plasma for cryoprecipitate production.
    Bass H; Trenchard PM; Mustow MJ
    Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
    Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage.
    Stokol T; Parry BW
    Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
    Johnson AJ; Macdonald VE; Brind J
    Vox Sang; 1979; 36(2):72-6. PubMed ID: 313629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the 'Mason' (continuous-thaw-siphon) method for cryoprecipitate production.
    Prowse CV; McGill A
    Vox Sang; 1979; 37(4):235-43. PubMed ID: 386613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in cryoprecipitate production.
    Rock G; Tittley P
    Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of qucik and slow thaw methods of producing cryoprecipitate antihaemophilic factor from fresh and 24-hour-old blood.
    Bloom AL; Giddings JC; Bevan B; Letton M; Drummond RJ
    J Clin Pathol; 1969 Jul; 22(4):447-52. PubMed ID: 5798632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates.
    López-Fernández MF; López-Berges C; Corral M; García-Talavera JR; López Borrasca A; Batlle J
    Vox Sang; 1987; 52(1-2):15-9. PubMed ID: 3111088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
    Morfini M; Longo G; Matucci M; Vannini S; Messori A; Filimberti E; Duminuco M; Avanzi G; Rossi-Ferrini P
    Ric Clin Lab; 1984; 14(4):681-91. PubMed ID: 6441235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Improved factor VIII yield in cryoprecipitate using a quick thaw technique.
    Davidson JF; McAdam JH; Mackenzie MJ; Kavanagh ML
    Thromb Diath Haemorrh; 1975 Nov; 34(2):590. PubMed ID: 1198502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.